Features of drug pharmacotherapy in patients with heart failure after pacemaker implantation
PDF (Українська)

Keywords

chronic heart failure
pacemaker implantation
drug therapy

How to Cite

Voronenko, O. (2020). Features of drug pharmacotherapy in patients with heart failure after pacemaker implantation. Medicine Today and Tomorrow, 88(3), 21-26. https://doi.org/10.35339/msz.2020.88.03.03

Abstract

Over the past decades, an increase in mortality from chronic heart failure (CHF) has been recorded, for the treatment of which the implantation of an electrocardiostimulator can be used. The medical support of the patient with a pacemaker was optimized depending on the functional class (FC) of CHF. An increase in both the frequency of prescription and the dose of (3-adrenergic receptor blockers with an increase in the FC of CHF in patients with CHF at a one-year follow-up period after implantation of pacemakers was shown. This not only improves myocardial contractility, but also reduces the risk of complications of pacing. Patients with implanted pacemakers require careful titration of medications taking into account the FC of CHF, especially with regard to its high FC, primarily for therapy with angiotensin-converting enzyme inhibitors, antiplatelet agents, and antiarrhythmic drugs.

Keywords: chronic heart failure, pacemaker implantation, drug therapy.

https://doi.org/10.35339/msz.2020.88.03.03
PDF (Українська)

References

Derzhavna sluzhba statystyky Ukrainy. (2020). Naselennia Ukrainy za 2019 rik. Demohrafichnyi shchorichnyk [Population of Ukraine 2019. Demographic Yearbook]. M. Timonina (Responsible for the release). Kyiv, 181 p. Retrieved from http://www.ukrstat.gov.ua/druk/publicat/kat_u/2020/zb/10/zb_nas_2019.pdf [in Ukrainian].

Ehorov, D.F., & Hordeiev, O.L. (2005). Diahnostika і lecheniie patsiientov s implantirovannymi antiaritmicheskimi ustroistvami [Diagnostics and treatment of patients with implanted antiarrhythmic devices]. St. Petersburg: Chelovek, 256 p. [in Russian].

Iqbal, J., Francis, L., & Reid, J. (2010). Quality of life in patients with chronic heart failure and their carers: a 3-year follow-up study assessing hospitalization and mortality. European Journal Heart Failure, vol. 12, issue 9, pp. 1002–1008. DOI: 10.1093/eurjhf/hfqll4. PMID: 20615920.

Gould, P.A., & Kaye, D.M. (2002). Clinical treatment regimens for chronic heart failure: a review. Expert Opin. Pharmacother., vol. 3, issue 11, pp. 1569–1576. DOI: 10.1517/14656566.3.11.1569. PMID: 12437491.

Lang, R. M., Badano, L. P., Mor-Avi, V., Afilalo, J., Armstrong, A., Ernande, L., … & Voigt, J. U. (2015). Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography, 28(1), 1–39.e14. DOI: 10.1016/j.echo.2014.10.003. PMID: 25559473.

Ponikowski, P, Voors, A.A., Anker, S.D., Bueno, H., Cleland, J.G.F., Coats, A. J.S. et al. (2016). ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur. Heart J., vol. 37, issue 27, pp. 2129–2200. DOI: 10.1093/eurheartj/ehwl28. PMID: 27206819.

Galderisi, M., Cosyns, B., Edvardsen, T., Cardim, N., Delgado, V., Di Salvo, G., et al. (2017). Standardization of adult transthoracic echocardiography reporting in agreement with recent chamber quantification, diastolic function, and heart valve disease recommendations: an expert consensus document of the European Association of Cardiovascular Imaging. Eur. Heart J. Cardiovasc. Imaging, vol. 18, issue 12, pp. 1301–1310. DOI: 10.1093/ehjci/jex244. PMID: 29045589.

Yancy, C.W., Jessup, M., Bozkurt, B. Butler, J., Casey, D.E.Jr., Colvin, M.M., et al. (2017). ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation, vol. 136, issue 6, pp. el37–el61. DOI: 10.1161/CIR.0000000000000509. PMID: 28455343.

Rekomendatsii Asotsiatsii kardiolohiv Ukrainy z diahnostyky ta likuvannia khronichnoi sertsevoi nedostatnosti [Recommendations of the Association of Cardiologists of Ukraine for the diagnosis and treatment of chronic heart failure]. (2017). Sertseva nedostatnist ta komorbidni stany - Heart Failure & Comorbidities, Kyiv, No.1 (Special issue. Addition No.1), pp. 1–66. Retrieved from https://strazhesko.org.ua/upload/ch_rekomendaciyi_dlya-sayta.pdf [in Ukrainian],

Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., … & ESC Scientific Document Group (2018). 2018 ESC/ESH Guidelines for the management of arterial hypertension. European heart journal, 39(33), 3021–3104. DOI: 10.1093/eurheartj/ehy339. PMID: 30165516.

Sychov, O.S. (moderator), Kovalenko, V.M., Dziak, H.V., Korkushko, A.V., Bobrov, V.O., & Hryn, V.K. (compilers). (2011). Diahnostyka ta likuvannia fibryliatsii peredserd. Rekomendatsii robochoi hrupy po porushenniam sertsevoho rytmu Asotsiatsii kardiolohiv Ukrainy [Diagnosis and treatment of atrial fibrillation. Recommendations of the working group on cardiac arrhythmias of the Association of Cardiologists of Ukraine], Kyiv, 159 p. Retrieved from https://strazhesko.org.ua/upload/2014/02/20/book_ukr_-10-2011-_preview.pdf [in Ukrainian].

Nasledov, A.D. (2007). SPSS. Kompiuternyi analiz dannykh vpsikholohii i sotsialnykh naukakh [SPSS. Computer Analysis of Data in Psychology and Social Sciences], St. Petersburg: Piter, 416 p. [in Russian].